home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  

registry of biomedical companies

  July 21, 2019
promoting the transfer of scientific know-how between industry and academia
Registry of biomedical companies:

[1] [3] [4] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Z] 527 active entries

MRC Holland

Willem Schoutenstraat 1
1057 DL Amsterdam The Netherlands

Phone: 31-88-8657200
Fax: 31-88-8657201

Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.


MRC Holland is the inventor and manufacturer of Multplex-ligation dependent Probe Amplification, or MLPA. MLPA® is a method that can detect copy number changes of up to 50 nucleic acid sequences in one simple reaction. MLPA® quickly identifies amplifications and deletions of a large number of genes, and can be used for DNA and mRNA profiling of both blood and tumour-derived samples. Furthermore, the MLPA® method can also be used to analyse CpG-methylation (MS-MLPA®). MLPA® has rapidly established its reputation as a trustworthy and efficient method. Hundreds of publications about the technique have appeared since its introduction in 2002, and MLPA® is now used in more than 900 laboratories worldwide.

Selected Categories:

Product Company   Service Company
- Research
- General
- in vitro

Last update of this entry: September 29, 2015

home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2019 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.